跳至主要内容
临床试验/NCT02810249
NCT02810249已完成不适用

Factors Affecting the Likely Use of PrEP for African American Young Men Who Have Sex With Men

Duke University0 个研究点目标入组 25 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
主要终点
Factors that influence African American YMSM's likely use of PrEP

研究概览

简要总结

HIV Pre-Exposure Prophylaxis (PrEP), in the form of the anti-retroviral pill Truvada©, has been approved by the FDA as a method for reducing HIV transmission rates in the population, particularly young men who have sex with men (YMSM). This study will use a qualitative design to interview 20-30, HIV-negative, 16-24 year old African American YMSM to: 1) identify and understand African American YMSM's, aged 16-24, cognitive and emotional processes in response to using PrEP to reduce their risk for HIV and 2) identify what factors (sociocultural, individual, experiences in health care, socioeconomic) influence African American YMSM's likely use of PrEP as a coping strategy for HIV prevention. Demographic information will be collected and analyzed using Statistical Analysis Software version 9.3. Individual interviews will be audio recorded and transcribed by a vetted transcription service for analysis. This is minimal risk to participants.

详细描述

This study will use an exploratory, naturalistic qualitative design where participants will be interviewed to collect data on their emotional and cognitive processes (illness representation) in response to the threat of a potential HIV infection, and what factors (social, cultural, individual characteristics, and experiences in health care) influence their likely use of PrEP. The sample for this study will include 20 to 30 African American YMSM, aged 16-24, residing in Durham, Wake, and Orange counties of North Carolina.

The in-depth interview guide and the 26-item descriptive survey PrEP Knowledge, Sexual History, and Demographic Instrument were developed for this study using a combination of the concepts from the adapted Common Sense Model of Illness Representation (CSM) and questions adapted from the Adolescent Trial Network's (ATN) 082 study's questionnaire. Participants will be asked questions relating to African American YMSM's likely use of HIV Pre-Exposure Prophylaxis (PrEP) as an HIV risk-reduction strategy. Once informed consent is obtained, the interview will commence and study participants will be individually interviewed to discuss what factors influence their likely use of PrEP. Each participant will complete the descriptive survey and the one-on-one interview.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Prospective

入排标准

年龄范围
16 Years 至 24 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • between the ages of 16-24
  • self-identify as African-American, Black, or mixed race including African American or Black
  • have been assigned male sex at birth
  • self-identify as gay, bisexual, or queer, or self-identify as a heterosexual male who has had a past voluntary sexual experience with another man or currently has sexual desires for men
  • report being uninfected with HIV
  • be mentally capable of providing informed consent
  • be able to speak and read English
  • not currently using PrEP for HIV.

排除标准

  • HIV-infected men are excluded because this study is focused on the prevention of HIV transmission
  • Men who were not assigned male sex at birth are excluded from this study, because transgender men face very different and distinct issues with access to care compared to YMSM
  • Men who are currently using PrEP are excluded from this study because this study is exploring the barriers and facilitators to use of PrEP in African American YMSM aged 16-
  • Men who are currently using PrEP may have a different illness representation compared to men who are not using PrEP.

结局指标

主要结局

Factors that influence African American YMSM's likely use of PrEP

时间窗: During patient interview, approximately 1.5 hours

Cognitive processes in response to using PrEP to reduce risk for HIV

时间窗: During patient interview, approximately 1.5 hours

Emotional processes in response to using PrEP to reduce risk for HIV

时间窗: During patient interview, approximately 1.5 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验